Erasca (NASDAQ:ERAS), Candel Therapeutics (NASDAQ:CADL), and Xencor (NASDAQ:XNCR) traded lower on Wednesday as Bank of America downgraded the trio of clinical-stage biotechs, citing a lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback